Back to GNMSF
Orbis Allan Gray Ltd GNMSF Position History
Genmab A/S • Healthcare
Quarters held
8
Latest value
$376.1M
Q3 2026
Peak value
$443.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1M |
| Q4 2025 | $443.1M |
| Q1 2026 | $896K |
| Q1 2026 | $345.9M |
| Q2 2026 | $311.4M |
| Q2 2026 | $917K |
| Q3 2026 | $865K |
| Q3 2026 | $376.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $376.1M | 10.54M | — | — |
| Q3 2026 | $865K | 24.2K | — | — |
| Q2 2026 | $917K | 33.4K | — | — |
| Q2 2026 | $311.4M | 11.33M | — | — |
| Q1 2026 | $345.9M | 12.89M | — | — |
| Q1 2026 | $896K | 33.4K | — | — |
| Q4 2025 | $443.1M | 14.39M | — | — |
| Q4 2025 | $1M | 33.4K | — | — |